Drug Approval | July 17, 2025
SMS Lifesciences India receives EIR with VAI status from USFDA for API facility at Kazipally
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
The receipt of EIR reaffirms the company's commitment to maintaining global quality standards
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
The inspection concluded with zero Form 483 observations
Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plants by volume
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Apitoria Pharma’s API manufacturing facility classified as VAI by USFDA
Amgen India investment totals $200 million through 2025
Krishna Institute of Medical Sciences Ltd enters into agreement with Splendid Hospitals
The conference featured comprehensive discussions, field visits, and knowledge-sharing sessions addressing different aspect of major NCDs
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Subscribe To Our Newsletter & Stay Updated
